Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print RSS Feed

Breaking News

Related Searches: Trials & Filings •
Orexigen Submits Contrave NDA

April 1, 2010
Obesity drug showed strong results in trials.  Read More »
Ricerca, LSP in BD Pact

April 1, 2010
Ricerca to reach Asian markets with development pact.  Read More »
Genzyme

March 31, 2010
Genzyme has appointed David Meeker to the newly created role of chief operating officer, designed to establish a sharper focus on commercial execution.  Read More »
GSK, Isis in RNA Therapeutics Pact

March 31, 2010
GlaxoSmithKline and Isis Pharmaceuticals have entered a strategic alliance that will apply Isis’ antisense drug discovery platform to develop new therapeutics against targets for rare and infectious diseases.  Read More »
Penn Pharma To Build New Cold Storage Facility

March 31, 2010
Penn Pharma is building a new 15,000ft. 2-8°C cold storage facility at its GMP warehouse in South Wales.   Read More »
Hospira Completes Acquisition of Orchid's Generic Injectable Unit

March 30, 2010
Hospira, Inc. has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., for approximately $400 million.  Read More »
Xeloda Combo Approved for Early Colon Cancer

March 30, 2010
Roche’s Xeloda (capecitabine) in combination with oxaliplatin (a combination known as XELOX) has been approved by the EMEA for the adjuvant treatment of patients with early colon cancer.  Read More »
GSK Re-submits Avodart sNDA

March 30, 2010
GlaxoSmithKline has re-submitted its sNDA for Avodart (dutasteride) to the FDA for prostate cancer risk reduction in men at increased risk of developing the disease.  Read More »
Thermo, Lilly Expand Clinical Pact

March 26, 2010
Thermo Fisher Scientific, Inc. and Eli Lilly and Co. have expanded their clinical trial materials supply chain relationship.   Read More »
Lonza May End Jazz Pharma Supply Pact

March 26, 2010
Lonza, Inc. has terminated its Sodium Gamma Hydroxybutyrate development and supply agreement with Jazz Pharmaceuticals, Inc.   Read More »
FDA Takes Enforcement Action at Genzyme Plant

March 25, 2010
The FDA has notified Genzyme Corp. that it intends to take enforcement action to ensure that products manufactured at the company’s Allston plant are made in compliance with GMP regulations.  Read More »
DPT Laboratories

March 25, 2010
Michael Curry has been named director of Sterile Operations at DPT Laboratories’ Center of Excellence for Sterile & Specialty Products, in Lakewood, NJ.  Read More »
Dainippon Sumitomo Lurasidone NDA Accepted for Review

March 25, 2010
Dainippon Sumitomo Pharma America, Inc.’s NDA for lurasidone for the treatment of acute schizophrenia has been accepted for review by the FDA.  Read More »
PPD Launches Vax/Bio Center of Excellence

March 24, 2010
PPD, Inc. is launching the Vaccines & Biologics Center of Excellence, a network of integrated lab services focused on vaccine and biologic drug development.  Read More »
Catalent Pharma Solutions

March 24, 2010
Lois Johnson has been appointed vice president of Quality, Development and Clinical Services, and Alex Eslava has been named vice president of Quality, Sterile Technologies, at Catalent Pharma Solutions.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: